Goldman Sachs’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,262
| Closed | -$9K | – | 5327 |
|
|
2022
Q3 | $9K | Sell |
1,262
-184
| -13% | -$1.31K | ﹤0.01% | 5268 |
|
|
2022
Q2 | $21K | Sell |
1,446
-103
| -7% | -$1.5K | ﹤0.01% | 5411 |
|
|
2022
Q1 | $58K | Buy |
1,549
+100
| +7% | +$3.74K | ﹤0.01% | 5439 |
|
|
2021
Q4 | $113K | Sell |
1,449
-4,051
| -74% | -$316K | ﹤0.01% | 5191 |
|
|
2021
Q3 | $554K | Sell |
5,500
-1,842
| -25% | -$186K | ﹤0.01% | 4332 |
|
|
2021
Q2 | $731K | Hold |
7,342
| – | – | ﹤0.01% | 4222 |
|
|
2021
Q1 | $721K | Buy |
+7,342
| New | +$721K | ﹤0.01% | 4129 |
|